Also after FDA approval we have a second possible scenario wich is Ironwood that could be interested in acquiring the company VTUS (very cheap and very interesting company) to be more attractive for a big buyout. Who knows ?
Thanks for the replies. I personally would like to see that they had revenue coming in before trying an acquisition. VTUS may be an interesting play in the future. Don't know enough about it. Can anyone think of why the FDA decision was delayed for IRWD? The FDA evidently didn't ask for more data. Simply not enough time to evaluate the drug safety profile, or something else. What do people think?
I have been watching IRWD for months now, waiting and waiting for the short hedgies to take their toll. This morning, I finally dipped my toes in and bought a bit. Way oversold, but the chart pattern still looks awful. I have cash in reserve to buy more should they take it back to the 52 week low (for no good reason). I think linaclotide has a good chance of being approved and if approved could become a blockbuster. I have watched all the investor presentations on the website and read the studies. I missed SLXP before it began its big run and don't want to miss this one too. I consider the product by the competitor SGYP to be at least 1-2 years down the road before possible approval. By that time, linaclotide could well have market share or be bought outright by Forest. Any counter thoughts? I would like to hear everyone's point of view.